U.S. flag

An official website of the United States government

NM_004260.4(RECQL4):c.1396C>G (p.Pro466Ala) AND Baller-Gerold syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 10, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000464723.7

Allele description [Variation Report for NM_004260.4(RECQL4):c.1396C>G (p.Pro466Ala)]

NM_004260.4(RECQL4):c.1396C>G (p.Pro466Ala)

Gene:
RECQL4:RecQ like helicase 4 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8q24.3
Genomic location:
Preferred name:
NM_004260.4(RECQL4):c.1396C>G (p.Pro466Ala)
HGVS:
  • NC_000008.11:g.144515237G>C
  • NG_016430.2:g.7590C>G
  • NG_033083.1:g.2273G>C
  • NM_004260.4:c.1396C>GMANE SELECT
  • NP_004251.3:p.Pro466Ala
  • NP_004251.4:p.Pro466Ala
  • LRG_277t1:c.1396C>G
  • LRG_277:g.7590C>G
  • LRG_277p1:p.Pro466Ala
  • NC_000008.10:g.145740621G>C
  • NG_016430.1:g.7590C>G
  • NM_004260.3:c.1396C>G
Protein change:
P466A
Links:
dbSNP: rs562809072
NCBI 1000 Genomes Browser:
rs562809072
Molecular consequence:
  • NM_004260.4:c.1396C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Baller-Gerold syndrome (BGS)
Synonyms:
Craniosynostosis radial aplasia syndrome; Craniosynostosis with radial defects
Identifiers:
MONDO: MONDO:0009039; MedGen: C0265308; Orphanet: 1225; OMIM: 218600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000546007Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Oct 10, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sensitivity of RECQL4-deficient fibroblasts from Rothmund-Thomson syndrome patients to genotoxic agents.

Jin W, Liu H, Zhang Y, Otta SK, Plon SE, Wang LL.

Hum Genet. 2008 Jul;123(6):643-53. doi: 10.1007/s00439-008-0518-4. Epub 2008 May 27.

PubMed [citation]
PMID:
18504617
PMCID:
PMC2585174

The mutation spectrum in RECQL4 diseases.

Siitonen HA, Sotkasiira J, Biervliet M, Benmansour A, Capri Y, Cormier-Daire V, Crandall B, Hannula-Jouppi K, Hennekam R, Herzog D, Keymolen K, Lipsanen-Nyman M, Miny P, Plon SE, Riedl S, Sarkar A, Vargas FR, Verloes A, Wang LL, Kääriäinen H, Kestilä M.

Eur J Hum Genet. 2009 Feb;17(2):151-8. doi: 10.1038/ejhg.2008.154. Epub 2008 Aug 20.

PubMed [citation]
PMID:
18716613
PMCID:
PMC2986053
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000546007.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 466 of the RECQL4 protein (p.Pro466Ala). This variant is present in population databases (rs562809072, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 407031). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RECQL4 protein function. This variant disrupts the p.Pro466 amino acid residue in RECQL4. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 18504617, 18716613, 23238538, 33046774). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024